7 research outputs found
Effects of Lactobacillus casei Shirota ingestion on common cold infection and herpes virus antibodies in endurance athletes: a placebo-controlled, randomized trial
Aims To assess evidence of health and immune benefit by
consumption of a Lactobacillus casei Shirota probiotic in
highly physically active people.
Methods Single-centre, population-based, randomized,
double-blind, placebo-controlled trial. Daily ingestion of
probiotic (PRO) or placebo (PLA) for 20 weeks for n = 243
(126 PRO, 117 PLA) university athletes and games players.
Subjects completed validated questionnaires on upper respiratory
tract infection symptoms (URS) on a daily basis
and on physical activity status at weekly intervals during
the intervention period. Blood samples were collected
before and after 20 weeks of the intervention for determination
of Epstein Barr virus (EBV) and cytomegalovirus
(CMV) serostatus and antibody levels.
Results URS episode incidence was unexpectedly low
(mean 0.6 per individual) and was not significantly different
on PRO compared with PLA. URS episode duration
and severity were also not influenced by PRO. A significant
time × group interaction effect was observed for plasma
CMV antibody titres in CMV seropositive participants
(p < 0.01) with antibody titre falling in the PRO group
but remaining unchanged in the PLA group over time. A
similar effect was found for plasma EBV antibody titres in
EBV seropositive participants (p < 0.01) with antibody titre
falling in the PRO group but increasing in the PLA group
over time. Conclusions In summary, regular ingestion of PRO did not
reduce URS episode incidence which might be attributable
to the low URS incidence in this study. Regular ingestion
of PRO reduced plasma CMV and EBV antibody titres, an
effect that can be interpreted as a benefit to overall immune
status
Immune cell status, cardiorespiratory fitness and body composition among breast cancer survivors and healthy women: a cross sectional study
Methods: We examined whether immune cell profiles differ between healthy women (n = 38) and breast cancer survivors (n = 27) within 2 years of treatment, and whether any group-differences were influenced by age, cytomegalovirus infection, cardiorespiratory fitness and body composition. Using flow cytometry, CD4+ and CD8+ T cell subsets, including naïve (NA), central memory (CM) and effector cells (EM and EMRA) were identified using CD27/CD45RA. Activation was measured by HLA-DR expression. Stem cell-like memory T cells (TSCMs) were identified using CD95/CD127. B cells, including plasmablasts, memory, immature and naïve cells were identified using CD19/CD27/CD38/CD10. Effector and regulatory Natural Killer cells were identified using CD56/CD16. Results: Compared to healthy women, CD4+ CM were +Δ21% higher among survivors (p = 0.028) and CD8+ NA were −Δ25% lower (p = 0.034). Across CD4+ and CD8+ subsets, the proportion of activated (HLA-DR+) cells was +Δ31% higher among survivors: CD4+ CM (+Δ25%), CD4+ EM (+Δ32%) and CD4+ EMRA (+Δ43%), total CD8+ (+Δ30%), CD8+ EM (+Δ30%) and CD8+ EMRA (+Δ25%) (p 0.305, p < 0.019). The association between fat mass index and HLA-DR+ CD8+ EMRA T cells withstood statistical adjustment for all variables, including age, CMV serostatus, lean mass and cardiorespiratory fitness, potentially implicating these cells as contributors to inflammatory/immune-dysfunction in overweight/obesity
Pre-sleep protein supplementation does not improve recovery from load carriage in British Army recruits (part 2)
British Army basic training (BT) is physically demanding with new recruits completing multiple bouts of physical activity each day with limited recovery. Load carriage is one of the most physically demanding BT activities and has been shown to induce acute exercise-induced muscle damage (EIMD) and impair muscle function. Protein supplementation can accelerate muscle recovery by attenuating EIMD and muscle function loss. This study investigated the impact of an additional daily bolus of protein prior to sleep throughout training on acute muscle recovery following a load carriage test in British Army recruits. Ninety nine men and 23 women (mean ± SD: age: 21.3 ± 3.5 yrs., height: 174.8 ± 8.4 cm, body mass 75.4 ± 12.2 kg) were randomized to dietary control (CON), carbohydrate placebo (PLA), moderate (20 g; MOD) or high (60 g; HIGH) protein supplementation. Muscle function (maximal jump height), perceived muscle soreness and urinary markers of muscle damage were assessed before (PRE), immediately post (POST), 24-h post (24 h-POST) and 40-h post (40 h-POST) a load carriage test. There was no impact of supplementation on muscle function at POST (p = 0.752) or 40 h-POST (p = 0.989) load carriage but jump height was greater in PLA compared to HIGH at 24 h-POST (p = 0.037). There was no impact of protein supplementation on muscle soreness POST (p = 0.605), 24 h-POST (p = 0.182) or 40 h-POST (p = 0.333). All groups had increased concentrations of urinary myoglobin and 3-methylhistidine, but there was no statistical difference between groups at any timepoint (p > 0.05). We conclude that pre-sleep protein supplementation does not accelerate acute muscle recovery following load carriage in British Army recruits during basic training. The data suggests that consuming additional energy in the form of CHO or protein was beneficial at attenuating EIMD, although it is acknowledged there were no statistical differences between groups. Although EIMD did occur as indicated by elevated urinary muscle damage markers, it is likely that the load carriage test was not arduous enough to reduce muscle function, limiting the impact of protein supplementation. Practically, protein supplementation above protein intakes of 1.2 g⸱kg−1⸱day−1 following load carriage over similar distances (4 km) and carrying similar loads (15–20 kg) does not appear to be warranted
Pre-sleep protein supplementation does not improve performance, body composition, and recovery in British Army recruits (part 1)
Dietary protein is crucial for optimising physical training adaptations such as muscular strength and mass, which are key aims for athletic populations, including British Army recruits. New recruits fail to meet the recommended protein intake during basic training (BT), with negligible amounts consumed in the evening. This study assessed the influence of a daily bolus of protein prior to sleep on performance adaptations, body composition and recovery in British Army recruits. 99 men and 23 women [mean ± standard deviation (SD): age: 21.3 ± 3.5 years, height: 174.8 ± 8.4 cm, body mass 75.4 ± 12.2 kg] were randomised into a dietary control (CON), carbohydrate placebo (PLA), moderate (20 g) protein (MOD) or high (60 g) protein (HIGH) supplementation group. Supplements were isocaloric and were consumed on weekday evenings between 2000 and 2100 for 12 weeks during BT. Performance tests (mid-thigh pull, medicine ball throw, 2 km run time, maximal push-up, and maximal vertical jump) and body composition were assessed at the start and end of BT. Dietary intake, energy expenditure, salivary hormones, urinary nitrogen balance, perceived muscle soreness, rating of perceived exertion, mood, and fatigue were assessed at the start, middle and end of BT. Protein supplementation increased protein intake in HIGH (2.16 ± 0.50 g⸱kg−1⸱day−1) and MOD (1.71 ± 0.48 g⸱kg−1⸱day−1) compared to CON (1.17 ± 0.24 g⸱kg−1⸱day−1) and PLA (1.31 ± 0.29 g⸱kg−1⸱day−1; p < 0.001). Despite this, there was no impact of supplementation on mid-thigh pull performance (CON = 7 ± 19%, PLA = 7 ± 19%, MOD = 0 ± 16%, and HIGH = 4 ± 14%; p = 0.554) or any other performance measures (p > 0.05). Fat-free mass changes were also similar between groups (CON = 4 ± 3%, PLA = 4 ± 4%, MOD = 3 ± 3%, HIGH = 5 ± 4%, p = 0.959). There was no impact of protein supplementation on any other body composition or recovery measure. We conclude no benefits of pre-bed protein supplementation to improve performance, body composition and recovery during BT. It is possible the training stimulus was great enough, limiting the impact of protein supplementation. However, the high degree of inter-participant variability suggests an individualised use of protein supplementation should be explored, particularly in those who consume sub-optimal (<1.6 g⸱kg−1⸱day−1) habitual amounts of protein.Clinical trial registration: The study was registered with ClinicalTrials.gov, U.S. national institutes (identifier: NCT05998590)
The effects of exercise training for eight weeks on immune cell characteristics among breast cancer survivors
MethodsThis study examined the effects of exercise training for 8 weeks on blood immune cell characteristics among 20 breast cancer survivors (age 56 ± 6 years, Body Mass Index 25.4 ± 3.0 kg m2) within two years of treatment. Participants were randomly allocated to a partly-supervised or a remotely-supported exercise group (n = 10 each). The partly supervised group undertook 2 supervised (laboratory-based treadmill walking and cycling) and 1 unsupervised session per week (outdoor walking) progressing from 35 to 50 min and 55% to 70% V˙O2max. The remotely-supported group received weekly exercise/outdoor walking targets (progressing from 105 to 150 min per week 55% to 70% V˙O2max) via weekly telephone calls discussing data from a fitness tracker. Immune cell counts were assessed using flow cytometry: CD4+ and CD8+ T cells (Naïve, NA; Central memory, CM; and Effector cells, EM and EMRA; using CD27/CD45RA), Stem cell-like memory T cells (TSCMs; using CD95/CD127), B cells (plasmablasts, memory, immature and naïve cells using CD19/CD27/CD38/CD10) and Natural Killer cells (effector and regulatory cells, using CD56/CD16). T cell function was assessed by unstimulated HLA-DR expression or interferon gamma (IFN-γ) production with Enzyme-linked ImmunoSpot assays following stimulation with virus or tumour-associated antigens.ResultsTotal leukocyte counts, lymphocytes, monocytes and neutrophils did not change with training (p > 0.425). Most CD4+ and CD8+ T cell subtypes, including TSCMs, and B cell and NK cell subtypes did not change (p > 0.127). However, across groups combined, the CD4+ EMRA T cell count was lower after training (cells/µl: 18 ± 33 vs. 12 ± 22, p = 0.028) and these cells were less activated on a per cell basis (HLA-DR median fluorescence intensity: 463 ± 138 vs. 420 ± 77, p = 0.018). Furthermore, the partly-supervised group showed a significant decrease in the CD4+/CD8+ ratio (3.90 ± 2.98 vs. 2.54 ± 1.29, p = 0.006) and a significant increase of regulatory NK cells (cells/µl: 16 ± 8 vs. 21 ± 10, p = 0.011). T cell IFN-γ production did not change with exercise training (p > 0.515).DiscussionIn summary, most immune cell characteristics are relatively stable with 8 weeks of exercise training among breast cancer survivors. The lower counts and activation of CD4+ EMRA T cells, might reflect an anti-immunosenescence effect of exercise
Effects of Lactobacillus casei Shirota ingestion on common cold infection and herpes virus antibodies in endurance athletes: a placebo-controlled, randomized trial
This article is distributed under the terms of the Creative
Commons Attribution 4.0 International License (http://creativecommons.
org/licenses/by/4.0/), which permits unrestricted use, distribution,
and reproduction in any medium, provided you give appropriate
credit to the original author(s) and the source, provide a link to the
Creative Commons license, and indicate if changes were made.Aims To assess evidence of health and immune benefit by
consumption of a Lactobacillus casei Shirota probiotic in
highly physically active people.
Methods Single-centre, population-based, randomized,
double-blind, placebo-controlled trial. Daily ingestion of
probiotic (PRO) or placebo (PLA) for 20 weeks for n = 243
(126 PRO, 117 PLA) university athletes and games players.
Subjects completed validated questionnaires on upper respiratory
tract infection symptoms (URS) on a daily basis
and on physical activity status at weekly intervals during
the intervention period. Blood samples were collected
before and after 20 weeks of the intervention for determination
of Epstein Barr virus (EBV) and cytomegalovirus
(CMV) serostatus and antibody levels.
Results URS episode incidence was unexpectedly low
(mean 0.6 per individual) and was not significantly different
on PRO compared with PLA. URS episode duration
and severity were also not influenced by PRO. A significant
time × group interaction effect was observed for plasma
CMV antibody titres in CMV seropositive participants
(p < 0.01) with antibody titre falling in the PRO group
but remaining unchanged in the PLA group over time. A
similar effect was found for plasma EBV antibody titres in
EBV seropositive participants (p < 0.01) with antibody titre
falling in the PRO group but increasing in the PLA group
over time. Conclusions In summary, regular ingestion of PRO did not
reduce URS episode incidence which might be attributable
to the low URS incidence in this study. Regular ingestion
of PRO reduced plasma CMV and EBV antibody titres, an
effect that can be interpreted as a benefit to overall immune
status